Premenopausal hysterectomy is associated with increased brain ferritin iron

Neurobiology of Aging

Volumn 33, Issue 9, 2012, Pages 1950-1958

  Tishler, Todd A ^a,b   Raven, Erika P ^a,b   Lu, Po H ^a   Altshuler, Lori L ^a,b   Bartzokis, George ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Dementia; Gender; Gray matter; Hysterectomy; Iron; Metal; Myelin; Oligodendrocytes; Prevention; Risk; Treatment; White matter

Indexed keywords

FERRITIN;

AGED; ARTICLE; BRAIN LEVEL; BRAIN REGION; CONTROLLED STUDY; FEMALE; FRONTAL LOBE; GRAY MATTER; HUMAN; HYSTERECTOMY; MALE; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; WHITE MATTER;

AGED; BRAIN; CASE-CONTROL STUDIES; FEMALE; FERRITINS; HUMANS; HYSTERECTOMY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NERVE FIBERS, MYELINATED; PREMENOPAUSE;

EID: 84863444666     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.08.002     Document Type: Article

References (69)

1. Barker W.W., Luis C.A., Kashuba A., Luis M., Harwood D.G., Loewenstein D., Waters C., Jimison P., Shepherd E., Sevush S., Graff-Radford N., Newland D., Todd M., Miller B., Gold M., Heilman K., Doty L., Goodman I., Robinson B., Pearl G., Dickson D., Duara R. Relative frequencies of Alzheimer disease, lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida brain bank. Alzheimer Dis. Assoc. Disord 2002, 16:203-212.
2. Bartzokis G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease. Neurobiol. Aging 2004, 25:5-18.
3. Bartzokis G. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 2011, 32:1341-1371.
4. Bartzokis G., Aravagiri M., Oldendorf W.H., Mintz J., Marder S.R. Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn. Reson. Med 1993, 29:459-464.
5. Bartzokis G., Cummings J.L., Markham C.H., Marmarelis P.Z., Treciokas L.J., Tishler T.A., Marder S.R., Mintz J. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn. Reson. Imaging 1999, 17:213-222.
6. Bartzokis G., Lu P.H., Mintz J. Human brain myelination and amyloid beta deposition in Alzheimer's disease. Alzheimers Dement 2007, 3:122-125.
7. Bartzokis G., Lu P.H., Tingus K., Peters D.G., Amar C.P., Tishler T.A., Finn J.P., Villablanca P., Altshuler L.L., Mintz J., Neely E., Connor J.R. Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology 2011, 36:1375-1384.
8. Bartzokis G., Lu P.H., Tishler T.A., Peters D.G., Kosenko A., Barrall K.A., Finn J.P., Villablanca P., Laub G., Altshuler L.L., Geschwind D.H., Mintz J., Neely E., Connor J.R. Prevalent iron metabolism gene variants associated with increase brain ferritin iron in healthy older men. J. Alzheimers Dis 2010, 20:333-341.
9. Bartzokis G., Sultzer D., Lu P.H., Nuechterlein K.H., Mintz J., Cummings J. Heterogeneous age-related breakdown of white matter structural integrity: Implications for cortical "disconnection" in aging and Alzheimer's disease. Neurobiol. Aging 2004, 25:843-851.
10. Bartzokis G., Tishler T.A., Lu P.H., Villablanca P., Altshuler L.L., Carter M., Huang D., Edwards N., Mintz J. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol. Aging 2007, 28:414-423.
11. Bartzokis G., Tishler T.A., Shin I.-S., Lu P.H., Cummings J.L. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann. N. Y. Acad. Sci 2004, 1012:224-236.
12. Beard J.L., Connor J.R. Iron Status and Neural Functioning. Annu. Rev. Nutr 2003, 23:41-58.
13. Borten O., Liberman A., Tuchweber B., Chevalier S., Ferland G., Schipper H.M. Effects of dietary restriction and metal supplementation on the accumulation of iron-laden glial inclusions in the aging rat hippocampus. Biogerontology 2004, 5:81-88.
14. Brett K.M. Can hysterectomy be considered a risk factor for cardiovascular disease?. Circulation 2005, 111:1456-1458.
15. Bulte J.W., Miller G.F., Vymazal J., Brooks R.A., Frank J.A. Hepatic hemosiderosis in non-human primates: quantification of liver iron using different field strengths. Magn. Reson. Med 1997, 37:530-536.
16. Bush A.I. The metallobiology of Alzheimer's disease. Trends Neurosci 2003, 26:207-214.
17. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1988, Lawrence Erlbaum Associates, Hillsdale, NJ.
18. Connor J.R., Menzies S.L. Relationship of iron to oligodendrocytes and myelination. Glia 1996, 17:83-93.
19. de los Monteros A.E., Korsak R.A., Tran T., Vu D., de Vellis J., Edmond J. Dietary iron and the integrity of the developing rat brain: a study with the artificially-reared rat pup. Cell. Mol. Biol 2000, 46:501-515. (Noisy-le-grand).
20. Dwork A.J. Effects of diet and development upon the uptake and distribution of cerebral iron. J. Neurol. Sci 1995, 134(Suppl):45-51.
21. Dwork A.J., Lawler G., Zybert P.A., Durkin M., Osman M., Willson N., Barkai A.I. An autoradiographic study of the uptake and distribution of iron by the brain of the young rat. Brain Res 1990, 518:31-39.
22. Engberink M.F., Geleijnse J.M., Durga J., Swinkels D.W., de Kort W.L., Schouten E.G., Verhoef P. Blood donation, body iron status and carotid intima-media thickness. Atherosclerosis 2008, 196:856-862.
23. Erb G.L., Osterbur D.L., LeVine S.M. The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. Brain Res. Dev. Brain Res 1996, 93:120-128.
24. Fleming D.J., Jacques P.F., Tucker K.L., Massaro J.M., D'Agostino R.B., Wilson P.W., Wood R.J. Iron status of the free-living, elderly Framingham Heart Study cohort: an iron-replete population with a high prevalence of elevated iron stores. Am. J. Clin. Nutr 2001, 73:638-646.
25. Floyd R.A., Carney J.M. The role of metal ions in oxidative processes and aging. Toxicol. Ind. Health 1993, 9:197-214.
26. Francois C., Nguyen-Legros J., Percheron G. Topographical and cytological localization of iron in rat and monkey brains. Brain Res 1981, 215:317-322.
27. Gerber M.R., Connor J.R. Do oligodendrocytes mediate iron regulation in the human brain?. Ann. Neurol 1989, 26:95-98.
28. Gould R.M., Freund C.M., Palmer F., Feinstein D.L. Messenger RNAs located in myelin sheath assembly sites. J. Neurochem 2000, 75:1834-1844.
29. Hallgren B., Sourander P. The effect of age on the non-haemin iron in the human brain. J. Neurochem 1958, 3:41-51.
30. Hill J.M., Switzer R.C. The regional distribution and cellular localization of iron in the rat brain. Neuroscience 1984, 11:595-603.
31. House M.J., St Pierre T.G., Milward E.A., Bruce D.G., Olynyk J.K. Relationship between brain R(2) and liver and serum iron concentrations in elderly men. Magn. Reson. Med 2010, 63:275-281.
32. Howard B.V., Kuller L., Langer R., Manson J.E., Allen C., Assaf A., Cochrane B.B., Larson J.C., Lasser N., Rainford M., Van Horn L., Stefanick M.L., Trevisan M. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation 2005, 111:1462-1470. Women's Health Initiative.
33. Hulet S.W., Menzies S., Connor J.R. Ferritin binding in the developing mouse brain follows a pattern similar to myelination and is unaffected by the jimpy mutation. Dev. Neurosci 2002, 24:208-213.
34. Jiao Y., Wilkinson J., Christine Pietsch E., Buss J.L., Wang W., Planalp R., Torti F.M., Torti S.V. Iron chelation in the biological activity of curcumin. Free Radic. Biol. Med 2006, 40:1152-1160.
35. Ke Y., Ming Qian Z. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol 2003, 2:246-253.
36. Kell D.B. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med. Genomics 2009, 2:2.
37. Kemper T. Neuroanatomical and neuropathological changes during aging and dementia. Clinical Neurology of Aging 1994, 3-67. Oxford University Press, New York. second ed. M. Albert, J. Knoefel (Eds.).
38. Kozak L.J., Owings M.F., Hall M.J. National Hospital Discharge Survey: 2001 annual summary with detailed diagnosis and procedure data. Vital Health. Stat 2004, 13:1-198.
39. Lavados M., Guillón M., Mujica M.C., Rojo L.E., Fuentes P., Maccioni R.B. Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. J. Alzheimers Dis 2008, 13:225-232.
40. Lehmann D.J., Schuur M., Warden D.R., Hammond N., Belbin O., Kolsch H., Lehmann M.G., Wilcock G.K., Brown K., Kehoe P.G., Morris C.M., Barker R., Coto E., Alvarez V., Deloukas P., Mateo I., Gwilliam R., Combarros O., Arias-Vasquez A., Aulchenko Y.S., Ikram M.A., Breteler M.M., van Duijn C.M., Oulhaj A., Heun R., Cortina-Borja M., Morgan K., Robson K., Smith A.D. Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project. Neurobiol. Aging 2010, in press. 10.1016/j.neurobiolaging.2010.07.018.
41. Lepine L.A., Hillis S.D., Marchbanks P.A., Koonin L.M., Morrow B., Kieke B.A., Wilcox L.S. Hysterectomy surveillance-United States, 1980-1993. MMWR CDC Surveill. Summary 1997, 46:1-15.
42. LeVine S.M., Macklin W.B. Iron-enriched oligodendrocytes: a reexamination of their spatial distribution. J. Neurosci. Res 1990, 26:508-512.
43. Li L., Fang C.J., Ryan J.C., Niemi E.C., Lebrón J.A., Björkman P.J., Arase H., Torti F.M., Torti S.V., Nakamura M.C., Seaman W.E. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3505-3510.
44. Mandel S.A., Amit T., Kalfon L., Reznichenko L., Weinreb O., Youdim M.B. Cell signaling pathways and iron chelation in the neurorestorative activity of green tea polyphenols: special reference to epigallocatechin gallate (EGCG). J. Alzheimers Dis 2008, 15:211-222.
45. Marner L., Nyengaard J.R., Tang Y., Pakkenberg B. Marked loss of myelinated nerve fibers in the human brain with age. J. Comp. Neurol 2003, 462:144-152.
46. Meyer A. Paul Flechsig's system of myelogenetic cortical localization in the light of recent research in neuroanatomy and neurophysiology part. Can. J. Neurol. Sci. II 1981, 8:95104.
47. Miech R.A., Breitner J.C., Zandi P.P., Khachaturian A.S., Anthony J.C., Mayer L. Incidence of AD may decline in the early 90s for men, later for women: The Cache County study. Neurology 2002, 58:209-218.
48. Morris C.M., Candy J.M., Oakley A.E., Bloxham C.A., Edwardson J.A. Histochemical distribution of non-haem iron in the human brain. Acta. Anat. (Basel) 1992, 144:235-257.
49. Peters A., Sethares C. Aging and the myelinated fibers in prefrontal cortex and corpus callosum of the monkey. J. Comp. Neurol 2002, 442:277-291.
50. Piñero D.J., Li N.Q., Connor J.R., Beard J.L. Variations in dietary iron alter brain iron metabolism in developing rats. J. Nutr 2000, 130:254-263.
51. Quintana C., Bellefqih S., Laval J.Y., Guerquin-Kern J.L., Wu T.D., Avila J., Ferrer I., Arranz R., Patiño C. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J. Struct. Biol 2006, 153:42-54.
52. Raber J., Huang Y., Ashford J.W. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol. Aging 2004, 25:641-650.
53. Rajendran R., Minqin R., Ynsa M.D., Casadesus G., Smith M.A., Perry G., Halliwell B., Watt F. A novel approach to the identification and quantitative elemental analysis of amyloid deposits-insights into the pathology of Alzheimer's disease. Biochem. Biophys. Res. Commun 2009, 382:91-95.
54. Salonen J.T., Korpela H., Nyyssönen K., Porkkala E., Tuomainen T.P., Belcher J.D., Jacobs D.R., Salonen R. Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers. J. Intern. Med 1995, 237:161-168.
55. Sanyal B., Polak P.E., Szuchet S. Differential expression of the heavy-chain ferritin gene in non-adhered and adhered oligodendrocytes. J. Neurosci. Res 1996, 46:187-197.
56. Schaie K.W., Willis S.L., Caskie G. The Seattle longitudinal study: Relationship between personality and cognition. Aging Neuropsychol. Cogn 2004, 11:304-324.
57. Smith M.A., Harris P.L., Sayre L.M., Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:9866-9868.
58. Smith M.A., Zhu X., Tabaton M., Liu G., McKeel D.W., Cohen M.L., Wang X., Siedlak S.L., Dwyer B.E., Hayashi T., Nakamura M., Nunomura A., Perry G. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis 2010, 19:363-372.
59. Sow A., Lamant M., Bonny J.M., Larvaron P., Piaud O., Lécureuil C., Fontaine I., Saleh M.C., Garcia Otin A.L., Renou J.P., Baron B., Zakin M., Guillou F. Oligodendrocyte differentiation is increased in transferrin transgenic mice. J. Neurosci. Res 2006, 83:403-414.
60. Srichairatanakool S., Ounjaijean S., Thephinlap C., Khansuwan U., Phisalpong C., Fucharoen S. Iron-chelating and free-radical scavenging activities of microwave-processed green tea in iron overload. Hemoglobin 2006, 30:311-327.
61. Todorich B., Pasquini J.M., Garcia C.I., Paez P.M., Connor J.R. Oligodendrocytes and myelination: The role of iron. Glia 2009, 57:467-478.
62. Turnbull S., Tabner B.J., Brown D.R., Allsop D. Generation of hydrogen peroxide from mutant forms of the prion protein fragment PrP121-231. Biochemistry 2003, 42:7675-7681.
63. Vymazal J., Brooks R.A., Baumgarner C., Tran V., Katz D., Bulte J.W., Bauminger R., Di Chiro G. The relation between brain iron and NMR relaxation times: An in vitro study. Magn. Reson. Med 1996, 35:56-61.
64. Vymazal J., Zak O., Bulte J.W., Aisen P., Brooks R.A. T1 and T2 of ferritin solutions: effect of loading factor. Magn. Reson. Med 1996, 36:61-65.
65. Whitfield J.B., Treloar S., Zhu G., Powell L.W., Martin N.G. Relative importance of female-specific and non-female-specific effects on variation in iron stores between women. Br. J. Haematol 2003, 120:860-866.
66. Yakovlev P.I., Lecours A.R. Regional Development of the Brain in Early Life 1967, Blackwell Scientific Publications, Boston.
67. Zecca L., Casella L., Albertini A., Bellei C., Zucca F.A., Engelen M., Zadlo A., Szewczyk G., Zareba M., Sarna T. Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease. J. Neurochem 2008, 106:1866-1875.
68. Zecca L., Youdim M.B., Riederer P., Connor J.R., Crichton R.R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci 2004, 5:863-873.
69. Zhang J., Li Y., Cui Y., Chen J., Lu M., Elias S.B., Chopp M. Erythropoietin treatment improves neurological functional recovery in EAE mice. Brain Res 2005, 1034:34-39.